LOAC Longevity Acquisition Corporation
Longevity Acquisition Corporation focuses on acquiring, engaging in a share exchange, share reconstruction and amalgamation, purchasing of assets, entering into contractual arrangements, or other business combination with one or more businesses. The company is based in Shanghai, the People's Republic of China.
On 10/22/2020 the company announced a pending merger with 4D pharma, a world leader in the development of Live Biotherapeutics, a novel and emerging class of drugs.
$13.40 +0.70 (5.51%)
As of 02/24/2021 16:00:00 EST IEX book CBOE book
Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Financials
Shell Companies
USA
10/16/2018
2,625,622
102,426
$35,183,335
0.00%
SEC Edgar Online
10-Q
10-K
Common stocks
Micro cap
Financials
Shell Companies
USA
10/16/2018
2,625,622
102,426
$35,183,335
0.00%
SEC Edgar Online
10-Q
10-K
Valuation (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
5.49
0.00
-11.72%
0.00%
5.49
0.00
-11.72%
0.00%